The pandemic spread of COVID-19 has had a major impact on the economy and lifestyle of the world.
On the other hand, mRNA vaccines, which have not received much attention as a modality, have saved many lives through rapid development and clinical application. Regenerative medicine is also a modality that still has a long way to go.

Regenerative medicine has the power to make the impossible possible, and just like mRNA drugs, it has the power to greatly change the society, and future of people. There are major barriers in regulations, technology, and practical application in providing regenerative medicine to many patients. Based on the experience and technology cultivated by J-TEC and the CMC capabilities of Teijin Pharma, we will deliver regenerative medicine to patients as quickly as possible through co-creation with related organizations in Japan and overseas. This is our commitments!!

November 2023
TEIJIN REGENET CO., LTD.
President
Yasushi Tanaka